Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome

Abstract

Objective To examine the utility of a low-dose estrogen and pulsed progestogen hormone replacement therapy (HRT) regimen for add-back during long-term gonadotropin-releasing hormone-agonist (GnRH-agonist) therapy. Design A pilot clinical trial conducted at a tertiary referral, academic, reproductive sciences center. The study included 15 patients with endometriosis and 5 patients with severe premenstrual syndrome (PMS). Patients with endometriosis received leuprolide acetate depot 3.75 mg IM monthly until their symptoms had resolved (2-3 months), at which time HRT was initiated along with the GnRH-agonist. Patients with severe PMS received the same treatment with the addition of HRT after 1 month. The HRT regimen consisted of 1 mg oral micronized estradiol daily and 0.35 mg norethindrone daily for 2 days alternating with 2 days without norethindrone. The main outcome measure included bone density assessment in the lumbar spine and femoral neck by dual-energy x-ray absorptiometry at 6- to 12-month intervals. The mean follow-up duration +/- SD while on GnRH-agonist treatment was 31.2 +/- 17 months (for endometriosis patients) and 37.7 +/- 8.4 months (for patients with severe PMS). Results Bone mineral density was stable after initiation of HRT for the entire follow-up period. No patient had return of pelvic pain or resumption of mood swings after HRT add-back. After the first 3 months of HRT, all women remained amenorrheic. Conclusions Long-term GnRH-agonist down-regulation is…

Overview

Integrity signals

Registry

Crossref · 10.1097/00042192-200207000-00004

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Research works printed but not linked: 6

  1. Casper, 1991, CMAJ, 144, 153
  2. Verkauf, 1987, J Fla Med Assoc, 74, 671
  3. Pickersgill, 1998, Br J Obstet Gynaecol, 105, 475, 10.1111/j.1471-0528.1998.tb10146.x · DOI
  4. Casper, 1996, J Soc Gynecol Investig, 3, 225, 10.1177/107155769600300501 · doi:10.1177/107155769600300501
  5. Steingold, 1987, Obstet Gynecol, 69, 403
  6. Warnock, 1997, Psychopharmacol Bull, 33, 311

Cited by

See all 53

Metadata

Authors
Mitwally, M. F. M., Gotlieb, L., & Casper, R. F.
Affiliations
Mount Sinai Hospital (CA)
Venue
Menopause
Published
2002-07
Volume
9
Issue
4
Pages
236-241
ISSN
1072-3714 (ISSN-L)
OpenAlex
W1971380616
Cited by
53
References
42
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
3.72
Type
journal article
Language
en
Open access
closed
Locations
  • Menopause The Journal of The North American Menopause Society (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
endometriosis, premenstrual syndrome, bone mineral density, estrogen replacement therapy, micronized estradiol, norethisterone, leuprolide, GnRH agonist down-regulation, estrogen deficiency, amenorrhea, bone loss prevention
MeSH terms
Administration, Oral, Adolescent, Adult, Delayed-Action Preparations, Densitometry, Drug Administration Schedule, Drug Therapy, Combination, Endometriosis, Estradiol, Female, Follow-Up Studies, Humans, Middle Aged, Osteoporosis, Pilot Projects, Premenstrual Syndrome, Reference Values, Severity of Illness Index, Bone Density, Leuprolide, Treatment Outcome, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. https://app.cochat.ai/papers/10.1097/00042192-200207000-00004
The paper
Mitwally, M. F. M., Gotlieb, L., & Casper, R. F. (2002). Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause. https://doi.org/10.1097/00042192-200207000-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.